Zoetis names James Saccaro CFO and COO, effective August 17, 2026
Zoetis appointed James (Jay) Saccaro, formerly CFO of GE HealthCare, as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. Current CFO Wetteny Joseph will move to a non-executive advisory role and remain with the company until February 28, 2027 or an earlier mutually agreed date. The change puts the finance function and Global Manufacturing and Supply under one executive.
Key points
- Saccaro's offer letter, dated July 31, 2026, sets a base salary of $1 million and a target annual incentive of 100% of base salary.
- Saccaro's annual target long-term incentive is $5 million, and he receives one-time make-whole awards of $6.25 million in restricted stock units and $1.25 million in cash.
- Joseph's role as CFO ends after August 16, 2026, or a later date set by the company; his separation benefits follow the Executive Severance Plan.
- Saccaro will serve as principal financial officer and principal accounting officer.
The filing
Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.